Preclinical evaluation of Genexol-PM, a nanoparticle formulation of paclitaxel, as a novel radiosensitizer for the treatment of non-small cell lung cancer (Q37113921)

From Wikidata
Jump to navigation Jump to search
scientific article published on July 2013
edit
Language Label Description Also known as
English
Preclinical evaluation of Genexol-PM, a nanoparticle formulation of paclitaxel, as a novel radiosensitizer for the treatment of non-small cell lung cancer
scientific article published on July 2013

    Statements

    Preclinical evaluation of Genexol-PM, a nanoparticle formulation of paclitaxel, as a novel radiosensitizer for the treatment of non-small cell lung cancer (English)
    Michael E Werner
    Natalie D Cummings
    Manish Sethi
    Edina C Wang
    Rohit Sukumar
    Dominic T Moore
    Andrew Z Wang
    1 July 2013
    463-468

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit